Matikas A, Zerdes I, Lövrot J, Richard F, Sotiriou C, Bergh J et al (2019) Prognostic implications of PD-L1 expression in breast cancer: systematic review and meta-analysis of immunohistochemistry and pooled analysis of transcriptomic data. Clin Cancer Res. https://doi.org/10.1158/1078-0432.CCR-19-1131

Article  PubMed  Google Scholar 

Otoshi T, Nagano T, Tachihara M, Nishimura Y (2019) Possible biomarkers for cancer immunotherapy. Cancers (Basel). https://doi.org/10.3390/cancers11070935

Article  PubMed  Google Scholar 

Bai R, Lv Z, Xu D, Cui J (2020) Predictive biomarkers for cancer immunotherapy with immune checkpoint inhibitors. Biomark Res. https://doi.org/10.1186/s40364-020-00209-0

Article  PubMed  PubMed Central  Google Scholar 

Barroso-Sousa R, Jain E, Cohen O, Kim D, Buendia-Buendia J, Winer E et al (2020) Prevalence and mutational determinants of high tumor mutation burden in breast cancer. Ann Oncol 167:671

Google Scholar 

Xin Y, Shen G, Zheng Y, Guan Y, Huo X, Li J et al (2021) Immune checkpoint inhibitors plus neoadjuvant chemotherapy in early triple-negative breast cancer: a systematic review and meta-analysis. BMC Cancer 21:1261

Article  CAS  PubMed  PubMed Central  Google Scholar 

Cortes J, Rugo HS, Cescon DW, Im S-A, Yusof MM, Gallardo C et al (2022) Pembrolizumab plus chemotherapy in advanced triple-negative breast cancer. N Engl J Med 387:217–226

Article  CAS  PubMed  Google Scholar 

Zou Y, Zou X, Zheng S, Tang H, Zhang L, Liu P et al (2020) Efficacy and predictive factors of immune checkpoint inhibitors in metastatic breast cancer: a systematic review and meta-analysis. Ther Adv Med Oncol. https://doi.org/10.1177/1758835920940928

Article  PubMed  PubMed Central  Google Scholar 

Zou Y, Hu X, Zheng S, Yang A, Li X, Tang H et al (2021) Discordance of immunotherapy response predictive biomarkers between primary lesions and paired metastases in tumours: a systematic review and meta-analysis. EBioMedicine 63:103137

Article  CAS  PubMed  Google Scholar 

Manson QF, Schrijver WAME, ter Hoeve ND, Moelans CB, van Diest PJ (2019) Frequent discordance in PD-1 and PD-L1 expression between primary breast tumors and their matched distant metastases. Clin Exp Metastasis 36:29–37

Article  CAS  PubMed  Google Scholar 

Boman C, Zerdes I, Mårtensson K, Bergh J, Foukakis T, Valachis A et al (2021) Discordance of PD-L1 status between primary and metastatic breast cancer: a systematic review and meta-analysis. Cancer Treat Rev 99:102257

Article  CAS  PubMed  Google Scholar 

Chung W, Eum HH, Lee H-O, Lee K-M, Lee H-B, Kim K-T et al (2017) Single-cell RNA-seq enables comprehensive tumour and immune cell profiling in primary breast cancer. Nat Commun. https://doi.org/10.1038/ncomms15081

Article  PubMed  PubMed Central  Google Scholar 

Zhao X, Qu J, Sun Y, Wang J, Liu X, Wang F et al (2017) Prognostic significance of tumor-associated macrophages in breast cancer: a meta-analysis of the literature. Oncotarget 5:46

Google Scholar 

Mahmoud SMA, Lee AHS, Paish EC, Macmillan RD, Ellis IO, Green AR (2012) Tumour-infiltrating macrophages and clinical outcome in breast cancer. J Clin Pathol. https://doi.org/10.1136/jclinpath-2011-200355

Article  PubMed  Google Scholar 

Noske A, Wagner D-C, Schwamborn K, Foersch S, Steiger K, Kiechle M et al (2021) 13P Comparison study of different programmed death-ligand 1 (PD-L1) assays, readers and scoring methods in triple-negative breast cancer (TNBC). Ann Oncol 32:S26

Article  Google Scholar 

Hong M, Kim JW, Kyoon Kim M, Wha Chung B, Kyung Ahn S (2020) Programmed cell death-ligand 1 expression in stromal immune cells is a marker of breast cancer outcome. J Cancer 11:7246–7252

Article  PubMed  PubMed Central  Google Scholar 

Zhang M, Sun H, Zhao S, Wang Y, Pu H, Wang Y et al (2017) Expression of PD-L1 and prognosis in breast cancer: a meta-analysis. Oncotarget 8:31347–31354

Article  PubMed  PubMed Central  Google Scholar 

Szekely B, Bossuyt V, Li X, Wali VB, Patwardhan GA, Frederick C et al (2018) Immunological differences between primary and metastatic breast cancer. Ann Oncol. https://doi.org/10.1093/annonc/mdy399

Article  PubMed  PubMed Central  Google Scholar 

Abad MN, Calabuig-Fariñas S, de Mena ML, Torres-Martínez S, González CG, García JÁG et al (2022) Programmed death-ligand 1 (PD-L1) as immunotherapy biomarker in breast cancer. Cancers (Basel) 14:307

Article  Google Scholar 

Lee H, Na KJ, Choi H (2021) Differences in tumor immune microenvironment in metastatic sites of breast cancer. Front Oncol. https://doi.org/10.3389/fonc.2021.649004

Article  PubMed  PubMed Central  Google Scholar 

Hilbers F, Venet D, Agostinetto E, Benelli M, Guerrero A, Martins-Branco D et al (2023) Characterization of the immune microenvironment in matched primary and metastatic breast cancer lesions from the AURORA study: BIG 14–01. J Clin Oncol 41:1009

Article  Google Scholar 

Bale R, Putzer D, Schullian P (2019) Local treatment of breast cancer liver metastasis. Cancers (Basel) 11:1341

Article  CAS  PubMed  Google Scholar 

Adam R, Aloia T, Krissat J, Bralet M-P, Paule B, Giacchetti S et al (2006) Is Liver resection justified for patients with hepatic metastases from breast cancer? Ann Surg 244:897–908

Article  PubMed  PubMed Central  Google Scholar 

Philip PA, Azar I, Xiu J, Hall MJ, Hendifar AE, Lou E et al (2022) Molecular characterization of KRAS wild-type tumors in patients with pancreatic adenocarcinoma. Clin Cancer Res 28:2704–2714

Article  CAS  PubMed  PubMed Central  Google Scholar 

Marabelle A, Fakih M, Lopez J, Shah M, Shapira-Frommer R, Nakagawa K et al (2020) Association of tumour mutational burden with outcomes in patients with advanced solid tumours treated with pembrolizumab: prospective biomarker analysis of the multicohort, open-label, phase 2 KEYNOTE-158 study. Lancet Oncol 21:1353–1365

Article  CAS  PubMed  Google Scholar 

Finotello F, Mayer C, Plattner C, Laschober G, Rieder D, Hackl H et al (2019) Molecular and pharmacological modulators of the tumor immune contexture revealed by deconvolution of RNA-seq data. Genome Med. https://doi.org/10.1186/s13073-019-0655-5

Article  PubMed  PubMed Central  Google Scholar 

Becht E, Giraldo NA, Lacroix L, Buttard B, Elarouci N, Petitprez F et al (2016) Estimating the population abundance of tissue-infiltrating immune and stromal cell populations using gene expression. Genome Biol 17:218

Article  PubMed  PubMed Central  Google Scholar 

Sidiropoulos DN, Rafie CI, Jang JK, Castanon S, Baugh AG, Gonzalez E et al (2022) Entinostat decreases immune suppression to promote antitumor responses in a HER2+ breast tumor microenvironment. Cancer Immunol Res 10:656–669

Article  CAS  PubMed  PubMed Central  Google Scholar 

Sidiropoulos DN, Rafie CI, Jang JK, Castanon S, Baugh AG, Gonzalez E et al (2022) Entinostat decreases immune suppression to promote antitumor responses in a HER2+ breast tumor microenvironment. Cancer Immunol Res Cancer Immunol Res 10:656–669

Article  CAS  PubMed  Google Scholar 

Zhang W, Kong X, Ai B, Wang Z, Wang X, Wang N et al (2021) Research progresses in immunological checkpoint inhibitors for breast cancer immunotherapy. Front Oncol. https://doi.org/10.3389/fonc.2021.582664

Article  PubMed  PubMed Central  Google Scholar 

Bao R, Stapor D, Luke JJ (2020) Molecular correlates and therapeutic targets in T cell-inflamed versus non-T cell-inflamed tumors across cancer types. Genome Med. https://doi.org/10.1186/s13073-020-00787-6

Article  PubMed  PubMed Central  Google Scholar 

Schnidrig D, Turajlic S, Litchfield K (2019) Tumour mutational burden: primary versus metastatic tissue creates systematic bias. Immuno-oncol Technol 4:8–14

Article  Google Scholar 

Tumeh PC, Hellmann MD, Hamid O, Tsai KK, Loo KL, Gubens MA et al (2017) Liver metastasis and treatment outcome with anti-PD-1 monoclonal antibody in patients with melanoma and NSCLC. Cancer Immunol Res 5:417–424

Article  CAS  PubMed  PubMed Central  Google Scholar 

Schurich A, Berg M, Stabenow D, Böttcher J, Kern M, Schild H-J et al (2010) Dynamic regulation of CD8 T cell tolerance induction by liver sinusoidal endothelial cells. J Immunol 184:4107–4114

Article  CAS  PubMed  Google Scholar 

Kaczmarek J, Homsi Y, van Üüm J, Metzger C, Knolle PA, Kolanus W et al (2014) Liver sinusoidal endothelial cell-mediated cd8 t cell priming depends on co-inhibitory signal integration over time. PLoS ONE 9:e99574

Article  PubMed  PubMed Central  Google Scholar 

Schildberg FA, Hegenbarth SI, Schumak B, Limmer A, Knolle PA (2008) Liver sinusoidal endothelial cells veto CD8 T cell activation by antigen-presenting dendritic cells. Eur J Immunol 38:957–967

Article  CAS  PubMed  Google Scholar 

Oh E, Hong J, Yun C-O (2019) Regulatory T cells induce metastasis by increasing Tgf-β and enhancing the epithelial-mesenchymal transition. Cells 8:1387

Article  CAS  PubMed  PubMed Central